SHTPY
Unknown Company
Price Chart
Latest Quote
$4.37
+0.00 (+0.00%)
Current Price
| Previous Close | $4.37 |
| Open | $4.50 |
| Day High | $4.50 |
| Day Low | $4.50 |
| Volume | 200 |
Stock Information
Note: Financial values converted from EUR to USD
| Quarterly Dividend / Yield | $0.05 / 1.20% |
| Shares Outstanding | 602.46M |
| Quarterly Dividend Yield | 1.20% |
| Quarterly Dividend | $0.05 |
| Total Debt | $358.41M |
| Cash Equivalents | $30.36M |
| Revenue | $1.17B |
| Net Income | $173.26M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $2.63B |
| P/E Ratio | 15.07 |
| EPS (TTM) | $0.29 |
| Exchange | PNK |
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $4.37 | 0 |
| 2026-06-17 | $4.37 | 0 |
| 2026-06-16 | $4.37 | 0 |
| 2026-06-15 | $4.37 | 0 |
| 2026-06-12 | $4.37 | 0 |
| 2026-06-11 | $4.37 | 0 |
| 2026-06-10 | $4.37 | 0 |
| 2026-06-09 | $4.37 | 0 |
| 2026-06-08 | $4.37 | 0 |
| 2026-06-05 | $4.37 | 0 |
| 2026-06-04 | $4.37 | 0 |
| 2026-06-03 | $4.37 | 0 |
| 2026-06-02 | $4.37 | 0 |
| 2026-06-01 | $4.37 | 0 |
| 2026-05-29 | $4.37 | 0 |
| 2026-05-28 | $4.37 | 0 |
| 2026-05-27 | $4.37 | 0 |
| 2026-05-26 | $4.37 | 0 |
| 2026-05-22 | $4.37 | 0 |
| 2026-05-21 | $4.37 | 0 |
| 2026-05-20 | $4.37 | 0 |
| 2026-05-19 | $4.37 | 0 |
About SHTPY
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
đ° Latest News
SCHOTT Pharma AG & Co. KGaA Just Beat EPS By 7.5%: Here's What Analysts Think Will Happen Next
Simply Wall St. âĸ 2026-05-16T08:42:25Z
Schott Pharma AG & CO KGaA (WBO:1SXP) Q2 2026 Earnings Call Highlights: Resilient ...
GuruFocus.com âĸ 2026-05-15T01:02:43ZIs Now An Opportune Moment To Examine SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)?
Simply Wall St. âĸ 2026-05-10T07:01:57Z
Schott Pharma AG & CO KGaA (SHTPY) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
GuruFocus.com âĸ 2026-02-11T17:01:15ZThere's A Lot To Like About SCHOTT Pharma KGaA's (ETR:1SXP) Upcoming âŦ0.18 Dividend
Simply Wall St. âĸ 2026-01-31T07:02:25Z
SCHOTT Pharma KGaA's (ETR:1SXP) Shareholders Will Receive A Bigger Dividend Than Last Year
Simply Wall St. âĸ 2025-12-22T13:01:14Z
Earnings Update: SCHOTT Pharma AG & Co. KGaA (ETR:1SXP) Just Reported And Analysts Are Trimming Their Forecasts
Simply Wall St. âĸ 2025-12-14T06:59:34Z
Schott Pharma AG & CO KGaA (WBO:1SXP) Q4 2025 Earnings Call Highlights: Strong Revenue ...
GuruFocus.com âĸ 2025-12-13T01:00:28ZA Look At The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Simply Wall St. âĸ 2025-11-21T09:12:35Z
What Does SCHOTT Pharma AG & Co. KGaA's (ETR:1SXP) Share Price Indicate?
Simply Wall St. âĸ 2025-10-24T11:00:40Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $653,746,000 | $634,481,000 | $582,113,000 | $524,717,000 |
| Cost Of Revenue | $653,746,000 | $634,481,000 | $582,113,000 | $524,717,000 |
| Total Revenue | $986,210,000 | $957,091,000 | $898,602,000 | $821,144,000 |
| Operating Revenue | $986,210,000 | $957,091,000 | $898,602,000 | $821,144,000 |
| Expenses | ||||
| Interest Expense | $20,011,000 | $13,487,000 | $7,254,000 | $2,686,000 |
| Total Expenses | $799,239,000 | $767,135,000 | $727,679,000 | $651,807,000 |
| Net Non Operating Interest Income Expense | $-12,638,000 | $-7,940,000 | $-2,303,000 | $-6,847,000 |
| Total Other Finance Cost | $575,000 | $412,000 | $276,000 | $6,301,000 |
| Interest Expense Non Operating | $20,011,000 | $13,487,000 | $7,254,000 | $2,686,000 |
| Operating Expense | $145,493,000 | $132,654,000 | $145,566,000 | $127,090,000 |
| Other Operating Expenses | $2,166,000 | $3,658,000 | $6,618,000 | $1,845,000 |
| Selling And Marketing Expense | $83,588,000 | $79,843,000 | $79,158,000 | $76,805,000 |
| General And Administrative Expense | $46,287,000 | $44,633,000 | $42,931,000 | $33,405,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $146,454,000 | $149,685,000 | $151,842,000 | $125,379,000 |
| Net Interest Income | $-12,638,000 | $-7,940,000 | $-2,303,000 | $-6,847,000 |
| Interest Income | $7,948,000 | $5,959,000 | $5,227,000 | $2,140,000 |
| Normalized Income | $147,192,369 | $150,360,659 | $150,172,462 | $133,809,975 |
| Net Income From Continuing And Discontinued Operation | $146,454,000 | $149,685,000 | $151,842,000 | $125,379,000 |
| Total Operating Income As Reported | $200,818,000 | $192,576,000 | $192,383,000 | $164,375,000 |
| Net Income Common Stockholders | $146,454,000 | $149,685,000 | $151,842,000 | $125,379,000 |
| Net Income | $146,454,000 | $149,685,000 | $151,842,000 | $125,379,000 |
| Net Income Including Noncontrolling Interests | $146,982,000 | $150,345,000 | $151,934,000 | $125,848,000 |
| Net Income Continuous Operations | $146,982,000 | $150,345,000 | $151,934,000 | $125,848,000 |
| Pretax Income | $187,756,000 | $183,971,000 | $185,802,000 | $158,288,000 |
| Special Income Charges | $-943,000 | $-827,000 | $2,041,000 | $-10,605,000 |
| Interest Income Non Operating | $7,948,000 | $5,959,000 | $5,227,000 | $2,140,000 |
| Operating Income | $186,971,000 | $189,956,000 | $170,923,000 | $169,337,000 |
| Gross Profit | $332,464,000 | $322,610,000 | $316,489,000 | $296,427,000 |
| Per Share | ||||
| Diluted EPS | $0.24 | $0.25 | $0.25 | $0.21 |
| Basic EPS | $0.24 | $0.25 | $0.25 | $0.21 |
| Other | ||||
| Tax Effect Of Unusual Items | $-204,631 | $-151,341 | $371,462 | $-2,174,025 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $288,150,000 | $263,263,000 | $242,863,000 | $226,936,000 |
| Total Unusual Items | $-943,000 | $-827,000 | $2,041,000 | $-10,605,000 |
| Total Unusual Items Excluding Goodwill | $-943,000 | $-827,000 | $2,041,000 | $-10,605,000 |
| Reconciled Depreciation | $79,440,000 | $64,978,000 | $51,848,000 | $55,357,000 |
| EBITDA (Bullshit earnings) | $287,207,000 | $262,436,000 | $244,904,000 | $216,331,000 |
| EBIT | $207,767,000 | $197,458,000 | $193,056,000 | $160,974,000 |
| Diluted Average Shares | $602,460,000 | $602,460,000 | $602,460,000 | $602,458,464 |
| Basic Average Shares | $602,460,000 | $602,460,000 | $602,460,000 | $602,458,464 |
| Diluted NI Availto Com Stockholders | $146,454,000 | $149,685,000 | $151,842,000 | $125,379,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Minority Interests | $-528,000 | $-660,000 | $-92,000 | $-469,000 |
| Tax Provision | $40,774,000 | $33,626,000 | $33,868,000 | $32,440,000 |
| Other Special Charges | $943,000 | $827,000 | $3,668,000 | $-965,000 |
| Research And Development | $27,918,000 | $24,254,000 | $26,822,000 | $23,527,000 |
| Selling General And Administration | $129,875,000 | $124,476,000 | $122,089,000 | $110,210,000 |
| Write Off | - | $0 | $-5,709,000 | $0 |
| Restructuring And Mergern Acquisition | - | - | $0 | $11,570,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $862,094,000 | $756,161,000 | $659,490,000 | $674,405,000 |
| Total Assets | $1,598,646,000 | $1,437,914,000 | $1,231,828,000 | $1,196,500,000 |
| Total Non Current Assets | $917,245,000 | $853,668,000 | $763,490,000 | $641,984,000 |
| Non Current Prepaid Assets | $342,000 | $319,000 | $432,000 | $329,000 |
| Non Current Deferred Taxes Assets | $13,042,000 | $14,330,000 | $14,828,000 | $11,748,000 |
| Investmentin Financial Assets | $1,000 | $6,000 | $18,000 | $4,000 |
| Goodwill And Other Intangible Assets | $29,689,000 | $30,467,000 | $30,941,000 | $32,873,000 |
| Other Intangible Assets | $1,263,000 | $1,120,000 | $1,450,000 | $1,920,000 |
| Current Assets | $681,401,000 | $584,246,000 | $468,338,000 | $554,516,000 |
| Hedging Assets Current | $5,994,000 | $3,227,000 | $3,716,000 | $1,044,000 |
| Prepaid Assets | $5,175,000 | $6,683,000 | $9,885,000 | $3,764,000 |
| Inventory | $174,975,000 | $146,262,000 | $138,943,000 | $128,936,000 |
| Other Receivables | $238,816,000 | $195,466,000 | $99,426,000 | $220,772,000 |
| Taxes Receivable | $29,417,000 | $31,289,000 | $24,989,000 | $23,288,000 |
| Accounts Receivable | $201,358,000 | $174,888,000 | $165,490,000 | $146,428,000 |
| Cash Cash Equivalents And Short Term Investments | $25,666,000 | $26,431,000 | $25,889,000 | $30,284,000 |
| Cash And Cash Equivalents | $22,470,000 | $23,182,000 | $24,357,000 | $28,795,000 |
| Cash Equivalents | $22,469,000 | $23,179,000 | $24,350,000 | $28,788,000 |
| Cash Financial | $1,000 | $3,000 | $7,000 | $7,000 |
| Other Current Assets | - | - | $2,460,000 | $1,038,000 |
| Debt | ||||
| Total Debt | $83,014,000 | $85,802,000 | $72,331,000 | $74,808,000 |
| Long Term Debt And Capital Lease Obligation | $79,203,000 | $80,874,000 | $69,193,000 | $71,433,000 |
| Current Debt And Capital Lease Obligation | $3,811,000 | $4,928,000 | $3,138,000 | $3,375,000 |
| Long Term Debt | - | - | - | $0 |
| Current Debt | - | - | - | $0 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $704,897,000 | $649,423,000 | $539,649,000 | $487,456,000 |
| Total Non Current Liabilities Net Minority Interest | $251,046,000 | $213,943,000 | $188,503,000 | $164,437,000 |
| Derivative Product Liabilities | $0 | $0 | $0 | $0 |
| Non Current Deferred Taxes Liabilities | $24,891,000 | $21,048,000 | $28,379,000 | $32,614,000 |
| Current Liabilities | $453,851,000 | $435,480,000 | $351,146,000 | $323,019,000 |
| Other Current Liabilities | $478,000 | $394,000 | $1,175,000 | $657,000 |
| Payables | $349,975,000 | $334,241,000 | $251,498,000 | $235,491,000 |
| Other Payable | $219,953,000 | $200,537,000 | $137,474,000 | $120,569,000 |
| Total Tax Payable | $26,143,000 | $38,192,000 | $23,380,000 | $15,326,000 |
| Accounts Payable | $103,879,000 | $95,512,000 | $90,644,000 | $99,596,000 |
| Dividends Payable | - | - | $0 | $0 |
| Other Non Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $891,783,000 | $786,628,000 | $690,431,000 | $707,278,000 |
| Total Equity Gross Minority Interest | $893,749,000 | $788,491,000 | $692,179,000 | $709,044,000 |
| Stockholders Equity | $891,783,000 | $786,628,000 | $690,431,000 | $707,278,000 |
| Other Equity Interest | $246,687,000 | $141,532,000 | $45,335,000 | $707,278,000 |
| Long Term Equity Investment | $88,498,000 | $85,056,000 | $79,055,000 | $79,821,000 |
| Retained Earnings | - | - | $36,953,000 | $681,908,000 |
| Other | ||||
| Ordinary Shares Number | $150,614,616 | $150,614,616 | $150,614,616 | $150,614,616 |
| Share Issued | $150,614,616 | $150,614,616 | $150,614,616 | $150,614,616 |
| Tangible Book Value | $862,094,000 | $756,161,000 | $659,490,000 | $674,405,000 |
| Invested Capital | $891,783,000 | $786,628,000 | $690,431,000 | $707,278,000 |
| Working Capital | $227,550,000 | $148,766,000 | $117,192,000 | $231,497,000 |
| Capital Lease Obligations | $83,014,000 | $85,802,000 | $72,331,000 | $74,808,000 |
| Total Capitalization | $891,783,000 | $786,628,000 | $690,431,000 | $707,278,000 |
| Minority Interest | $1,966,000 | $1,863,000 | $1,748,000 | $1,766,000 |
| Additional Paid In Capital | $494,481,000 | $494,481,000 | $494,481,000 | $0 |
| Capital Stock | $150,615,000 | $150,615,000 | $150,615,000 | $0 |
| Common Stock | $150,615,000 | $150,615,000 | $150,615,000 | $0 |
| Non Current Pension And Other Postretirement Benefit Plans | $23,573,000 | $27,204,000 | $18,777,000 | $14,625,000 |
| Non Current Deferred Revenue | $116,700,000 | $78,611,000 | $66,139,000 | $39,949,000 |
| Long Term Capital Lease Obligation | $79,203,000 | $80,874,000 | $69,193,000 | $71,433,000 |
| Long Term Provisions | $6,656,000 | $5,994,000 | $6,001,000 | $5,750,000 |
| Current Capital Lease Obligation | $3,811,000 | $4,928,000 | $3,138,000 | $3,375,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $35,701,000 | $36,819,000 | $46,832,000 | $39,787,000 |
| Current Provisions | $9,917,000 | $10,262,000 | $5,263,000 | $9,802,000 |
| Available For Sale Securities | $1,000 | $6,000 | $18,000 | $4,000 |
| Goodwill | $28,426,000 | $29,347,000 | $29,491,000 | $30,953,000 |
| Net PPE | $785,673,000 | $723,490,000 | $637,805,000 | $517,209,000 |
| Accumulated Depreciation | $-589,244,000 | $-536,011,000 | $-489,436,000 | $-462,129,000 |
| Gross PPE | $1,374,917,000 | $1,259,501,000 | $1,127,241,000 | $979,338,000 |
| Construction In Progress | $205,073,000 | $192,490,000 | $250,619,000 | $173,474,000 |
| Machinery Furniture Equipment | $812,345,000 | $730,545,000 | $615,671,000 | $565,373,000 |
| Properties | $357,499,000 | $336,466,000 | $260,951,000 | $240,491,000 |
| Finished Goods | $41,096,000 | $38,386,000 | $20,984,000 | $40,124,000 |
| Work In Process | $26,407,000 | $20,608,000 | $48,881,000 | $20,152,000 |
| Raw Materials | $107,472,000 | $87,268,000 | $91,301,000 | $86,261,000 |
| Other Short Term Investments | $3,196,000 | $3,249,000 | $1,532,000 | $1,489,000 |
| Inventories Adjustments Allowances | - | $-30,816,000 | $-22,223,000 | $-17,601,000 |
| Non Current Accrued Expenses | - | - | $0 | $0 |
| Other Properties | - | - | - | - |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $35,163,000 | $79,473,000 | $6,128,000 | $29,435,000 |
| Operating Activities | ||||
| Operating Cash Flow | $179,920,000 | $224,769,000 | $181,652,000 | $182,123,000 |
| Investing Activities | ||||
| Capital Expenditure | $-144,757,000 | $-145,296,000 | $-175,524,000 | $-152,688,000 |
| Investing Cash Flow | $-159,033,000 | $-255,442,000 | $-171,411,000 | $-142,135,000 |
| Net Other Investing Changes | $-15,918,000 | $-109,513,000 | - | $-1,000 |
| Financing Activities | ||||
| Financing Cash Flow | $-21,082,000 | $31,914,000 | $-11,395,000 | $-42,382,000 |
| Net Other Financing Charges | $8,289,000 | $58,449,000 | $11,168,000 | $-29,236,000 |
| Cash Dividends Paid | $-24,098,000 | $-22,592,000 | $-18,878,000 | $-11,456,000 |
| Common Stock Dividend Paid | $-24,098,000 | $-22,592,000 | $-18,878,000 | $-11,456,000 |
| Dividend Received Cfo | $2,250,000 | $4,250,000 | $2,000,000 | $0 |
| Dividends Received Cfi | - | - | - | $0 |
| Other | ||||
| End Cash Position | $22,470,000 | $23,182,000 | $24,357,000 | $28,795,000 |
| Beginning Cash Position | $23,182,000 | $24,357,000 | $28,795,000 | $27,859,000 |
| Effect Of Exchange Rate Changes | $-517,000 | $-2,416,000 | $-3,284,000 | $3,330,000 |
| Changes In Cash | $-195,000 | $1,241,000 | $-1,154,000 | $-2,394,000 |
| Net Investment Purchase And Sale | $0 | $-2,142,000 | $-663,000 | $-1,806,000 |
| Sale Of Investment | $2,601,000 | $0 | - | - |
| Purchase Of Investment | $-2,601,000 | $-2,142,000 | $-663,000 | $-1,806,000 |
| Net Intangibles Purchase And Sale | $-434,000 | $-221,000 | $-57,000 | $-677,000 |
| Purchase Of Intangibles | $-434,000 | $-221,000 | $-57,000 | $-677,000 |
| Net PPE Purchase And Sale | $-142,681,000 | $-143,566,000 | $-170,691,000 | $-139,652,000 |
| Sale Of PPE | $1,642,000 | $1,509,000 | $4,776,000 | $12,359,000 |
| Purchase Of PPE | $-144,323,000 | $-145,075,000 | $-175,467,000 | $-152,011,000 |
| Change In Working Capital | $-37,761,000 | $12,263,000 | $-13,703,000 | $1,600,000 |
| Change In Other Current Liabilities | $-10,013,000 | $14,650,000 | $16,778,000 | $-4,767,000 |
| Change In Other Current Assets | $41,797,000 | $9,166,000 | $20,107,000 | $17,749,000 |
| Change In Payable | $10,049,000 | $8,470,000 | $-3,903,000 | $29,112,000 |
| Change In Inventory | $-29,461,000 | $-3,414,000 | $-15,380,000 | $-30,637,000 |
| Change In Receivables | $-60,845,000 | $-16,956,000 | $-32,432,000 | $-35,572,000 |
| Other Non Cash Items | $-9,887,000 | $-5,118,000 | $-4,148,000 | $829,000 |
| Depreciation And Amortization | $79,440,000 | $64,978,000 | $51,848,000 | $55,357,000 |
| Amortization Cash Flow | $500,000 | $669,000 | $969,000 | $1,318,000 |
| Depreciation | $78,940,000 | $64,309,000 | $50,879,000 | $54,039,000 |
| Gain Loss On Investment Securities | $-773,000 | $-1,364,000 | $-685,000 | - |
| Gain Loss On Sale Of PPE | $-331,000 | $-585,000 | $-394,000 | $-1,511,000 |
| Net Income From Continuing Operations | $146,982,000 | $150,345,000 | $151,934,000 | $125,848,000 |
| Repayment Of Debt | - | $0 | $-15,000 | $0 |
| Net Issuance Payments Of Debt | - | $0 | $-15,000 | $18,000 |
| Net Long Term Debt Issuance | - | $0 | $-15,000 | $18,000 |
| Long Term Debt Payments | - | $0 | $-15,000 | $0 |
| Issuance Of Debt | - | - | $0 | $18,000 |
| Long Term Debt Issuance | - | - | $0 | $18,000 |
| Other Cash Adjustment Outside Changein Cash | - | - | - | $1,000 |
| Sale Of Intangibles | - | - | - | $0 |
Fetched: 2026-02-02